BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 16107691)

  • 1. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
    Ho JS; Ma W; Mao DY; Benchimol S
    Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H; Wu X
    Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascochlorin, an isoprenoid antibiotic, induces G1 arrest via downregulation of c-Myc in a p53-independent manner.
    Jeong JH; Chang YC
    Biochem Biophys Res Commun; 2010 Jul; 398(1):68-73. PubMed ID: 20558137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
    Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
    Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma.
    Mitani Y; Oue N; Hamai Y; Aung PP; Matsumura S; Nakayama H; Kamata N; Yasui W
    J Pathol; 2005 Jan; 205(1):65-73. PubMed ID: 15586362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
    Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
    J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1.
    Hermeking H; Funk JO; Reichert M; Ellwart JW; Eick D
    Oncogene; 1995 Oct; 11(7):1409-15. PubMed ID: 7478565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.
    Xu D; Popov N; Hou M; Wang Q; Björkholm M; Gruber A; Menkel AR; Henriksson M
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3826-31. PubMed ID: 11274400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-independent induction of G1 arrest and p21WAF1/CIP1 expression by ascofuranone, an isoprenoid antibiotic, through downregulation of c-Myc.
    Jeong JH; Kang SS; Park KK; Chang HW; Magae J; Chang YC
    Mol Cancer Ther; 2010 Jul; 9(7):2102-13. PubMed ID: 20587660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc-mediated transcriptional repression by recruitment of histone deacetylase.
    Kurland JF; Tansey WP
    Cancer Res; 2008 May; 68(10):3624-9. PubMed ID: 18483244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced G1 cell-cycle arrest controls replication-dependent histone mRNA 3' end processing through p21, NPAT and CDK9.
    Pirngruber J; Johnsen SA
    Oncogene; 2010 May; 29(19):2853-63. PubMed ID: 20190802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.
    Claassen GF; Hann SR
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9498-503. PubMed ID: 10920185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.
    Gartel AL; Ye X; Goufman E; Shianov P; Hay N; Najmabadi F; Tyner AL
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4510-5. PubMed ID: 11274368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.